Botulinum Toxin Therapy for Diseases in the Oral and Maxillofacial Regions

A special issue of Toxins (ISSN 2072-6651). This special issue belongs to the section "Bacterial Toxins".

Deadline for manuscript submissions: 30 March 2025 | Viewed by 147

Special Issue Editor


E-Mail
Guest Editor
Department of Oral and Maxillofacial Surgery, National Hospital Organization, Kyoto Medical Center, Kyoto 612-8555, Japan
Interests: movement disorders; oromandibular dystonia; botulinum toxin therapy; orofacial pain; temporomandibular disorders; oral dyskinesia; neurophysiology; sleep apnea syndrome; oral appliance therapy
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Botulinum toxin therapy can be indicated for various diseases of the oral and maxillofacial regions, including oromandibular dystonia, orolingual dyskinesia, trigeminal neuralgia, orofacial pain, temporomandibular joint dislocation, tremors, tics, functional involuntary movements, temporomandibular joint disorders, bruxism, sialorrhea, and Frey’s syndrome. If injections are performed carefully with an understanding of the local anatomy, botulinum toxin therapy has been shown to be effective with minimal severe side effects. Cooperation between medical and dental professionals is crucial for the diagnosis and treatment of these diseases. However, the number of diseases for which botulinum has been officially approved is limited in some countries. Although there are large differences depending on the disease, most of the results are based on open studies, and there are limited studies with high-quality evidence. In the future, it will be necessary to conduct research with a high level of evidence, either at multiple facilities or between medical and dental professionals and clinical trials, to obtain official approval for the use of botulinum toxin for the aforementioned diseases. Thus, the purpose of this Special Issue is to discuss the current achievements in botulinum toxin therapy for diseases of the oral and maxillofacial regions as well as future prospects from the perspective of experts in each field. I am pleased to request that you contribute original research or reviews concerning botulinum toxin therapy for oral and maxillofacial diseases. The research areas we will consider include neurology, otorhinolaryngology, neurosurgery, psychiatry, dermatology, oral and maxillofacial surgery, dentistry, and prosthodontics. I eagerly anticipate your contributions.

Dr. Kazuya Yoshida
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a double-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Toxins is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • botulinum toxin therapy
  • movement disorders
  • oromandibular dystonia
  • trigeminal neuralgia
  • orofacial pain
  • temporomandibular disorders
  • sialorrhea
  • bruxism
  • tremor
  • tic

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop